Aldesleukin Terminated Phase 1 / 2 Trials for Metastatic Melanoma / Metastatic Renal Cancer / Metastatic Cancers Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00923806Gene Therapy Using Anti-CEA Cells to Treat Metastatic Cancer